Problem: The primary care provider is considering prescribing a sodium-glucose cotransporter 2 (SGLT2) inhibitor as a second-line treatment for a patient with type 2 diabetes. What potential side effect are you concerned about? Question options: A) hyperglycemia B) urinary tract infection C) edema D) hypertension